Search results for: 'research area tyrosine kinase fak'
-
A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
B2172 PP121Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|HckSummary: Dual inhibitor of tyrosine and phosphoinositide kinases
-
A4125 CYC116Target: Aurora Kinases|FLT3|VEGFRSummary: Potent Aurora A/B inhibitor
-
A1778 Vatalanib (PTK787) 2HClTarget: VEGFRSummary: Tyrosine kinase receptor inhibitor
-
B1439 Golvatinib (E7050)Target: VEGFRSummary: C-Met/VEGFR-2 inhibitor
-
A4150 WHI-P154Target: VEGFR|Src|EGFR|JAKSummary: JAK3 inhibitor
-
A3870 TG 100801Target: VEGFR|FGFR|Src|Fyn kinaseSummary: Multi-kinase inhibitor
-
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).
-
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor